WithdrawnPhase 1NCT02050776

Stem Cell Therapy in Limb Girdle Muscular Dystrophy

Studying Limb-girdle muscular dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Neurogen Brain and Spine Institute
Principal Investigator
Alok K Sharma, M.S., M.Ch
Neurogen Brain and Spine Institute
Intervention
Autologous bone marrow mononuclear cell transplantation(biological)
Eligibility
15-60 years · All sexes
Timeline
20082013

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02050776 on ClinicalTrials.gov

Other trials for Limb-girdle muscular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Limb-girdle muscular dystrophy

← Back to all trials